| |
FDA Approval Activities for this Drug
Raplon (rapacuronium bromide) Injection,100 mg/5 mL, 200 mg/10 mL Vial. Organon, Inc NDA 20-984 8/18/99 9/24/99 9/24/99 7/2/01
Raplon Indications: Indicated for outpatients and inpatients as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures.
For the latest approval information and links for this API, please see the main page.
|